Is it safe to perform a caudal epidural on a patient taking double dose aspirin (acetylsalicylic acid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Caudal Epidural Injection in Patients on Double Dose Aspirin

Performing a caudal epidural injection while on double dose aspirin is not recommended due to the increased risk of epidural hematoma, which could lead to significant morbidity and mortality. 1

Risk Assessment for Neuraxial Procedures with Aspirin

General Guidelines for Aspirin and Neuraxial Procedures

  • While standard dose aspirin is not an absolute contraindication for central neuraxial anesthesia, double dose aspirin presents a higher bleeding risk 1
  • The French Working Group on Perioperative Haemostasis (GIHP) states that aspirin monotherapy at standard doses may be continued for central neuraxial anesthesia if the benefit-risk ratio is favorable 1
  • However, this recommendation applies to standard dosing, not double dosing

Risk Stratification

Caudal epidural injections are classified as central neuraxial procedures with the following considerations:

  • They access the epidural space, where bleeding can lead to spinal cord compression
  • Compression of neural structures in this area can result in permanent neurological damage
  • The epidural space cannot be easily compressed if bleeding occurs 1

Evidence of Complications

Multiple case reports document epidural hematomas following neuraxial procedures in patients on aspirin:

  • An 80-year-old woman developed a spinal epidural hematoma after spinal cord stimulator trial while taking aspirin, requiring emergency neurosurgical intervention 2
  • A 73-year-old woman on low-dose aspirin (81 mg/day) developed an epidural hematoma following spinal cord stimulator lead placement 3
  • A 79-year-old man on aspirin for secondary prevention developed an epidural hematoma after an interlaminar epidural steroid injection 4

Recommendations Based on Procedure Type

For Central Neuraxial Procedures (including Caudal Epidurals):

  • Standard dose aspirin monotherapy may be continued if there are no other abnormalities of hemostasis or anticoagulant therapy 1
  • Single-puncture spinal anesthesia is preferable to epidural anesthesia when aspirin is continued 1
  • Double dose aspirin represents a higher bleeding risk and should be discontinued before the procedure

For Peripheral Nerve Blocks:

  • Low bleeding risk peripheral blocks (e.g., femoral, axillary, popliteal sciatic blocks) can be performed in patients on aspirin therapy 1, 5
  • High bleeding risk peripheral blocks (e.g., infraclavicular, para-sacral sciatic, posterior lumbar plexus blocks) may be performed in patients on aspirin monotherapy if the benefit-risk ratio is favorable 1

Management Algorithm for Patients on Double Dose Aspirin Needing Caudal Epidural

  1. Assess indication for double dose aspirin:

    • If for secondary prevention after recent myocardial infarction or stent placement, consult with the prescribing cardiologist
    • If for primary prevention, consider temporarily reducing to standard dose or discontinuing
  2. Risk mitigation options:

    • Postpone the caudal epidural until aspirin dose can be reduced to standard dose
    • Consider alternative pain management approaches:
      • Low bleeding risk peripheral nerve blocks 1, 5
      • Non-invasive pain management strategies
  3. If caudal epidural is absolutely necessary:

    • Reduce aspirin to standard dose (81-100 mg daily) at least 3-5 days before the procedure
    • Use ultrasound guidance by an experienced operator 1
    • Monitor closely for signs of epidural hematoma post-procedure

Post-Procedure Monitoring

If a caudal epidural is performed in a patient on any dose of aspirin, careful monitoring is essential for:

  • New or worsening neurological symptoms
  • Back pain
  • Bladder or bowel dysfunction
  • Motor or sensory deficits

Key Considerations

  • The risk of epidural hematoma must be weighed against the risk of thrombotic events if aspirin is discontinued
  • For patients with recent coronary stents or acute coronary syndrome, discontinuing antiplatelet therapy carries significant risks 1
  • In these cases, consider delaying the elective caudal epidural or using alternative pain management approaches

In conclusion, while standard dose aspirin may be continued for neuraxial procedures in selected patients, double dose aspirin significantly increases bleeding risk and should be avoided when performing caudal epidural injections.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Nerve Blocks Guideline

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.